3-42125630-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001042646.3(TRAK1):c.286+16T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000439 in 1,613,296 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00071 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00041 ( 1 hom. )
Consequence
TRAK1
NM_001042646.3 intron
NM_001042646.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.469
Genes affected
TRAK1 (HGNC:29947): (trafficking kinesin protein 1) Predicted to enable GABA receptor binding activity and myosin binding activity. Involved in endosome to lysosome transport. Located in early endosome and mitochondrion. Implicated in developmental and epileptic encephalopathy 68. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 3-42125630-T-C is Benign according to our data. Variant chr3-42125630-T-C is described in ClinVar as [Benign]. Clinvar id is 1906249.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRAK1 | NM_001042646.3 | c.286+16T>C | intron_variant | ENST00000327628.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TRAK1 | ENST00000327628.10 | c.286+16T>C | intron_variant | 1 | NM_001042646.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000710 AC: 108AN: 152202Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
108
AN:
152202
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000882 AC: 219AN: 248370Hom.: 1 AF XY: 0.000846 AC XY: 114AN XY: 134792
GnomAD3 exomes
AF:
AC:
219
AN:
248370
Hom.:
AF XY:
AC XY:
114
AN XY:
134792
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000411 AC: 600AN: 1461094Hom.: 1 Cov.: 30 AF XY: 0.000376 AC XY: 273AN XY: 726790
GnomAD4 exome
AF:
AC:
600
AN:
1461094
Hom.:
Cov.:
30
AF XY:
AC XY:
273
AN XY:
726790
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000710 AC: 108AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.00106 AC XY: 79AN XY: 74354
GnomAD4 genome
AF:
AC:
108
AN:
152202
Hom.:
Cov.:
32
AF XY:
AC XY:
79
AN XY:
74354
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 22, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at